Want to see HK:2393 full AI Analyst Report?
Yestar Healthcare Holdings Co Ltd (2393) Stock Price & Analysis
2393 Stock Chart & Stats
- Day’s Range
- HKD 0.05 - HKD 0.05
- 52-Week Range
- HKD 0.04 - HKD 0.14
- Previous Close
- HKD 0.05
- Volume
- N/A
- Average Volume (3M)
- 373.92K
- Market Cap
- HKD 114.15M
- Enterprise Value
- HKD 177.64M
- Total Cash (Recent Filing)
- HKD 194.45M
- Total Debt (Recent Filing)
- HKD 202.47M
- Price to Earnings (P/E)
- ―
- Beta
- 0.59
- Next Earnings
- Mar 26, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Jun 05, 2018
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Improved Balance Sheet
Debt reduction and the return to positive equity have materially improved financial flexibility compared with 2021–2023. A moderate 2025 debt-to-equity position lowers balance-sheet strain and provides a stronger foundation for sustaining clinic operations and funding future priorities.
Strong 2025 Cash Generation
The sharp rebound in operating and free cash flow shows that the business converted activity into cash despite reported net losses. If maintained, this cash generation can support ongoing medical facilities, reduce financing dependence, and provide resilience during earnings volatility.
Established Clinic Service Model
A branded clinic network with in-house medical professionals gives Yestar an established delivery platform for recurring patient services and multiple treatment categories. This operating base can support utilization improvements, cross-selling, and customer retention as demand conditions stabilize.
Bears Say
Sharp Revenue Contraction
The latest revenue decline indicates weakened demand or clinic volume and directly pressures the scale economics of a consumer-facing healthcare network. Continued contraction would limit operating leverage, reduce reinvestment capacity, and make recovery in earnings more difficult over the next several quarters.
Unstable Profitability
A return to net losses after an apparently non-recurring margin surge shows that reported earnings are not yet dependable. Volatile profitability makes planning and capital allocation harder, while persistent losses could offset the benefits of improved leverage and strong recent cash flow.
Volatile Cash Flow Durability
The 2025 cash-flow improvement is encouraging but has not yet demonstrated consistency across the cycle. Prior negative operating and free cash flow suggest that a downturn or weaker clinic demand could again reduce internally generated funds, limiting financial resilience and investment capacity.
Yestar Healthcare Holdings Co Ltd News
Yestar Healthcare to Liquidate Key Medical Equipment Subsidiary in China
Yestar Healthcare Holdings Co Ltd ( ($HK:2393) ) has provided an announcement. Yestar Healthcare Holdings has moved to voluntarily liquidate Guangzhou Shengshiyuan Trading, an indirect non–wholly owned subsidiary in Guangzhou
2393 FAQ
What was Yestar Healthcare Holdings Co Ltd’s price range in the past 12 months?
What is Yestar Healthcare Holdings Co Ltd’s market cap?
When is Yestar Healthcare Holdings Co Ltd’s upcoming earnings report date?
How were Yestar Healthcare Holdings Co Ltd’s earnings last quarter?
Is Yestar Healthcare Holdings Co Ltd overvalued?
Does Yestar Healthcare Holdings Co Ltd pay dividends?
What is Yestar Healthcare Holdings Co Ltd’s EPS estimate?
How many shares outstanding does Yestar Healthcare Holdings Co Ltd have?
What happened to Yestar Healthcare Holdings Co Ltd’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Yestar Healthcare Holdings Co Ltd?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Yestar Healthcare Holdings Co Ltd
Yestar Healthcare Holdings Company Limited, an investment holding company, manufactures, distributes, and sells medical imaging products in Mainland China. The company operates in two segments, Imaging Printing Products, and Medical Products and Equipment. The Imaging Printing Products segment manufactures and sells color photographic paper and industrial NDT x-ray films and PWB films, as well as trades in imaging equipment. The Medical Products and Equipment segment manufactures and sells medical dry, medical wet, and dental films, as well as sells medical equipment and diagnostic reagents. The company also engages in the management of supply chain and service of freight transportation equipment, as well as development of biotechnology. The company was formerly known as Yestar International Holdings Company Limited and changed its name to Yestar Healthcare Holdings Company Limited in January 2017. Yestar Healthcare Holdings Company Limited was founded in 1971 and is headquartered in Shanghai, the People’s Republic of China.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Chun Lai Wang
- Employees
- 400
- Website
- www.yestarcorp.com
- Address
- Green Land Building, Shanghai, SH, 201199, CN
Yestar Healthcare Holdings Co Ltd (2393) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 3 | 14 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 0 | 0 | 12 |








